Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab

• DOI: 10.1212/wnl.0b013e3182918d27
• Publication Date: 2013-04-25T02:39:19Z
• Authors: Jennifer Yeung; Cécile Cauquil; Guillaume Saliou; Ghaida Nasser; Sophio Rostomashvili; David Adams; Marie Théaudin
• Keywords: Natalizumab; Varicella zoster virus; Immunosuppression; JC Virus

We report a case of varicella-zoster virus (VZV) myelitis in woman with relapsing-remitting multiple sclerosis (RRMS) receiving natalizumab, humanized monoclonal antibody that induces an immunosuppression localized to the CNS.